BrightOwl Loader Loading

Summary

geofrey de visscher (MSc-phd-mba) is a multi-lingual product innovator with >15 years’ experience in of creative development group management for Medical Device, biotech and pharma. having started academia (vub, University maastricht, kuleuven and University of antwerp), he transited into industry by founding his Medical Device - biotech company (anethon) based on his own invention. this experience was then of great value for setting up and leading the r&d group at nitto’s (japanese business" >B2B materials company developing Medical Devices) swiss centre, quickly rising to the head of r&d position. presently, geofrey is cto of elanix Biotechnologies, developing progenitor Cell based Dermatology products and responsible for Manufacturing.

his entrepreneurial interest have been further developed by undertaking the emba Training at imd, where he further analysed the entrepreneurial experience and wrote a case study about the human and team aspects of Start-ups.

geofrey’s Leadership combines a perpetual drive to acquire and implement knowledge, and need to mentor people to achieve original and exciting new technologies and business opportunities. the ability of spreading his creativity and excitement over the team led to several project conceptions and executions, yet always in touch with the market needs. this part of geofrey’s character has been recognized by his subordinates and superiors as he is described as an “independent team builder and Leader” with “great motivator skills in a result driven and entrepreneurial fashion”. over his Career his teams have been responsible for > 20 patent families, of which he co-invented 16, in various fields (cardiovascular, wound healing, …)

Experiences

Current Experience

  • Chief Technology Officer

    Nyon, Switzerland
    Since January 2018

    ◦ heading the development of a product portfolio including Medical Devices,
    specialty cosmetics, otc pharma and Cell based products
    ◦ company product Strategy development, including Marketing support and business case assessment
    ◦ negotiate, establish and manage external r&d and Manufacturing partners (CMO)
    ◦ new and complementary product and technology scouting
    ◦ ip portfolio development and management

    ◦ Heading the development of a product portfolio including medical devices,
    specialty cosmetics, OTC Pharma and cell based products
    ◦ Company product strategy development, including marketing support and business case assessment
    ◦ Negotiate, establish and manage external R&D and manufacturing partners (CMO)
    ◦ New and complementary product and technology scouting
    ◦ IP portfolio development and management

Past Experience

  • Head of Research & Development Lausanne, Switzerland

    September 2016 --- June 2017

    ◦ coached and led 6-person direct and 2-person indirect team & maintain the permissive environment

    ◦ performed and directed business Due Diligence on potential wind Energy, agricultural and petrol/gas sector projects

    ◦ performed and directed technical/regulatory Due Diligence and business case development for new Veterinary IVD technology

    ◦ evaluated european customer voice for the Veterinary IVD project

    ◦ readjusted the r&d projects upon second change of cto

    ◦ reported directly to japanese higher management (cto; 4/year)

    ◦ contributed to over 20 patent families filed on various domains over the 5 years at nitto denko

  • Product Development & QS Manager Lausanne, Switzerland

    October 2014 --- August 2016

    ◦ coached and led 6-person direct and 2-person indirect team & maintain

    the permissive environment

    ◦ built and managed a dekra certified iso13485 compliant Quality Management System (10% of time)

    ◦ managed key opinion leaders in us, eu & canada

    ◦ initiated the derisking efforts of our Research lines upon change of cto

    ◦ performed and directed european technology scouting within the life science, cleantech, Energy and agricultural domain

    ◦ performed and directed technical and business related Due Diligence of potential technologies

    ◦ reported directly to japanese higher management (cto; 4/year)

     

  • Product Development Manager Lausanne, Switzerland

    August 2013 --- September 2014

    ◦ expended and coached a multidisciplinary team of 6 direct reports

    ◦ created an environment permissive to Innovation and instrumental to the high patent output of the group (on average 4/year)

    ◦ ramped up the Preclinical evaluation by performing large animal proof of concept studies

    ◦ supervised the setting up and Validation of in house safety Testing according to ISO 10993

    ◦ defined the regulatory approval path for the combination device under development

    ◦ reported directly to japanese higher management (cto; 4/year)

     

  • Senior Scientist Research (Biology) Lausanne, Switzerland

    August 2012 --- July 2013

    ◦ coached and led a 3-person team

    ◦ developed Laboratory facilities in switzerland

    ◦ designed and achieved approval for a Research program, based on multiple information sources, in line with set timelines, goals and Budgets to develop a new accelerated wound healing solution

    ◦ discovered active compounds to be implemented into Medical Devices

    ◦ reported directly to japanese higher management (cto; 4/year)

     

  • Senior Scientist Genk, Belgium

    May 2012 --- July 2012

    see position above

  • Co-founder & CSO Leuven, Belgium

    November 2011 --- May 2012

    ◦ managed a 2-person team

    ◦ developed a full Business Strategy plan, licensed the University’s ip

    ◦captured 250 k€and 500k$ in hard and soft vc commitment, respectively, to attract the first CEO, a Clinical Director and Manufacturing director

     

  • Research & Innovation Manager for EGAMI Antwerp, Belgium

    February 2010 --- October 2011

    ◦ prospected and acquired new projects with industrial partners

    ◦ conceived funding Applications, internal and external, with the eye on industrial applicability and ip generation

    ◦ performed the local Marketing, incl. Marketing material development, organising events and website to increase the consortiums renown in flanders

     

  • Entrepreneur

    January 2006 --- February 2010
    the spin-off project is a business related project based on our own patented technology and which comprised all preparative steps to found a spin-off company (see above for anethon nv). Entrepreneur • prepare anethon business case and strategic plan o write business plan o Market Analysis and prognosis o Regulatory Affairs plan and EMA scientific advice o write patent Applications o CMO identification (recombinant Protein & blood plasma product) • present for investors: private, companies and vc funds

  • Laboratory Head - Cardiovascular Tissue Engineering Leuven, Belgium

    December 2001 --- February 2010

    ◦ led and mentored 6 direct and 2 indirect reports, administering a €250k capex and €3m Budgets

    ◦ executed the Project Management for industrial services: Preclinical device assessment

    ◦ invented a (1) new coating for cardiovascular devices and (2) Biomarkers for cardiovascular tissue development

    ◦ conceived the pivotal criteria and rationale for the negotiations for a €800k angel investor contribution to the development of the coating technology to become anethon

    ◦ performed surgical Research as a core Member of the labs Research service team: trained in anaesthesia, echocardiography and Surgery

    ◦ developed the Tissue Engineering Lab; attract the right competences and build the necessary facilities

    ◦ supervised 5phd theses and several MSc theses

     

  • AIO (PhD student Maastricht, Netherlands

    January 1999 --- November 2001

    janssen pharmaceutica sponsored phd position.

    completed dictoral thesis in In Vivo infrared Spectroscopy and conducted scientific Medical Research

     

  • Scientific co-worker Brussels, Belgium

    October 1997 --- November 1998

    Research focused in genetic damage and genotoxicity induced by mercury in the brain, especially linked to epileptogenicity.

Personality

Self Assessment :
Innovative thinkingInterest in knowledgeCritical thinkingAnalytical thinkingApproachabilityAuthenticityIndependenceProblem solvingResiliencyStrategic thinking

Knowledge

Self Assessment :
Animal models Biostatistics Cell biology Negotiation R&DAnalysisAnimal trialAssay developmentBiologyBiomarkersBiomedical SciencesBiotechnologyBudget ManagementBudget NegotiationBudgetingBusiness DevelopmentBusiness IntelligenceBusiness PlanningBusiness StrategyCardiovascular diseasesCell biologyCell CultureCell SignalingCellular Product DevelopmentCoachingCross-functional team leadershipData AnalysisDatabase design and maintenanceDesign of Experiments (DOE) Diagnostic marketDue DiligenceELISAEnglishEntrepreneurshipExperimentationFinancial AnalysisGeneticsGenomicsImmunohistochemistry (IHC)ImmunologyIn vitro diagnostics (IVD)InflammationInnovation ManagementISO 13485Laboratory ManagementLaboratory study designLeadershipLife SciencesLifesciencesMammalian Cell CultureMarket AnalysisMedical Device R&DMedical DevicesMicrosoft ExcelMicrosoft OfficeMicrosoft PowerpointMicrosoft ProjectMicrosoft WordMolecular & Cellular BiologyMultilingualPatentspeople managementPre-clinical researchPreclinical developmentPreclinical SafetyPresentation SkillsProduct developmentProject ManagementResearchSPSSStart-upsStatistical Data AnalysisTeam LeadershipTeam ManagementTechnological InnovationVascular surgery
LinkedIn Assessment :
LifesciencesMicroscopyGeneticsscienceCell biologyImmunohistochemistryLaboratoryToxicologyResearchELISAAnimal ModelsClinical DevelopmentMedical DevicesProject ExecutionInventorLife SciencesProject ConceptionScientific WritingNeuroscienceTeam LeadershipStatisticsHistologySPSScardiovascularWound CarePre-clinical StudiesZEN (microscopy software)Tissue EngineeringISO 13485ISO 10993FileMakerBiotechnologyProject Management

Skills and Expertise

Self Assessment :
research and developmentbusiness developmentproduct developmentinnovation managementteam managementcoachingMentoring Analytical skillsKey Opinion Leader Management

Education

  • Master in Executive Master of Businedd Administration (till Nov 2017) from IMD in 2017
  • in Foundations for Business Leadership from IMD Business School in 2016
  • PhD in Brain perfusion, oxygenation and metabolism from Universiteit Maastricht in 2002
  • Master in Biology from Vrije Universiteit Brussel in 1997
  • none in Produktontwikkeling from Artesis Hogeschool Antwerpen in 1993
  • Sciences/Mathematics in High school from Koninklijk Atheneum III Gent in 1990

Training and Certification

  • Certificaat Proefdierleider (Felasa C) in 0000 Certification
  • Certificate Medical Biostatistics in 0000 Certification
  • Personal License under Animals Act in 0000 Certification

Languages

BrightOwl Assessment:
Self Assessment:
Dutch
Native
English
Full Proficiency
French
Professional Proficiency
German
Elementary Proficiency

Work Preferences

  • Notice Period:
    1 week
  • Positions I am interested in:
    CSO General Manager Managing Director R&D Director
  • Work From Home:
    No
  • Work Regime:
    Permanent position :    100% FTE
  • International:
    Yes

Area / Region

Lausanne, Switzerland

Others

Driving License
  • Yes

Similar Candidates

Other Candidates in Switzerland

Other Candidates in Lausanne

Other Candidates

Most Recent Searches

Most Famous Searches

You might also like